| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5954594 | Chest | 2014 | 9 Pages |
Abstract
Fibulin-1 is a novel potential biomarker for disease progression in IPF and raises the possibility that it could be used as a target for the development of new treatments.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jade BSc, Sofia BSc, Tamera J. MBBS, PhD, Michael MBBS, Paul J. MD, PhD, Luca MD, PhD, Stefania MD, PhD, Cecilia M. PhD, Philip M. PhD, William Scott PhD, Rema A. PhD, Brian G. PhD, Judith L. MBBS, PhD, Janette K. PhD,